Real-World Evidence Platform
for Peptide Medicine
$100K/day
Current Daily Snapshot
$500K/day
Target Daily Volume
100%
Clinical
Significant savings for doctors and more justifiable billable codes.
How Medicine Works Today — And Why It Fails
The Broken Workflow
- Doctors use clipboards, paper forms, and fax machines
- Patients don't remember their medical history
- 90% skip most fields on intake forms
- Staff manually types illegible handwriting into EMRs
- Doctor gets 10–20 seconds to review a chart
- Doctors ask these intake questions because malpractice insurance requires it — not because it improves patient care
The Endless Cycle
Doctor writes a prescription. If it doesn't work, the patient comes back and they try again. An endless cycle of guesswork — no data, no context, no continuity.
No core diagnosis is ever found. Patients take five, six, nine different medications that are basically band-aids — they don't ever help the patient get better, they just put band-aids on all the problems.
Cost before patient sits down: -$300 per acquisition
This is called practicing medicine because they are literally practicing.
What We Built — One System That Changes Everything
Patient Books Online
Receives a text with a HIPAA consent link — signs in 30 seconds.
15-Year History Retrieved
System queries every institution the patient has visited. All labs, blood work, surgeries, medications, allergies, and x-rays — pulled in seconds.
Seamless EMR Integration
Integrates directly into the doctor's existing EMR. AI identifies gaps in care automatically.
Doctor Gets Full Summary
1-3 page patient summary delivered before the patient arrives. Zero manual work.
Three New Revenue Events Before the Patient Sits Down
Medical Record Retrieval
$150–$180
CPT code for querying full patient history across all institutions visited in the past 15 years.
Medical Triage
$100–$120
Updating the EMR and onboarding the patient into the practice — fully automated.
Gaps-in-Care Analysis
$100–$149
AI-driven identification of missed screenings, undiagnosed conditions, and care gaps.
BEFORE
-$300 per patient acquisition cost
AFTER
+$350–$450 total new revenue per patient
NET SWING
+$650 to +$750 per patient visit
Research Program
Patient Savings
Compliance
Real Treatment at $.25 on the Dollar, and Dropping..
"Instead of $600–$1,000, join our research program and get the same products for $50 to $100."
The Peptide Advantage
Instead of 5–9 medications that are band-aids, our software surfaces peptides that address ailments at their core — not just masking symptoms.
Fully compliant enrollment
60-second iPad onboarding
Peptides at $.25 on the dollar, with a target to get to $.18 on the dollar
Patient saves $450–$850 per cycle
IRB-Approved Research
Every enrolled patient becomes part of an IRB-approved research study — generating real-world evidence with every interaction.
- Patient enrollment takes 60 seconds on an iPad: First name, last name, DOB, zip code, 3–4 questions, scan ID. That's it.
Under the research protocol, no prescription is required. The doctor can sell medications directly to the patient.
Recurring Revenue Every Single Month
How Remote Patient Monitoring Works
Doctor calls patient monthly. Checks in on peptide protocols. Our software records the actual conversation between doctor and patient and automatically updates their profile. Zero manual charting required.
Monthly Billing
$120 to $380, and in some cases $425 per month per patient
50 Patients → $6K–$21.25K/mo RPM billing alone
Revenue Stacks Month Over Month
1
Month 1
Onboard 50 patients → $17.5K–$22.5K one-time
2
Month 2+
RPM billing kicks in → $6K–$21.25K/mo
3
Month 6+
Data licensing revenue begins → $5K–$50K per record
The Most Valuable Healthcare Database Ever Collected
Every patient interaction generates data: medical history, gaps identified, peptide protocols, monthly outcomes, dosage changes, biomarkers. This is Real-World Evidence — and pharma companies like Novo Nordisk and Eli Lilly need it for New Drug Applications.
Traditional clinical study costs $3–6M. Our RWE data sells for 6–9x as much — and we collect it as a byproduct of patient care.
Why RWE data is worth 6–9x more: Real-world data captures what labs cannot — patients who forget to take their diabetes medication one day, patients who don't eat frequently, patients with irregular sleep patterns. Real adherence, real outcomes, real life. This is what pharma companies need to substantiate FDA submissions.
All data stored on HIPAA-compliant government cloud. Non-invasive to PHI. Fully anonymized for licensing.
All data is accumulated into our algorithm-based AI engine, compartmentalized for data aggregation — structured and anonymized for sale to pharmaceutical companies at scale.
$5K–$50K
Per Patient Record
Individual RWE data value
$1M–$5M+
Per Curated Dataset
Per each individual buyer / Pharmaceutical company
$3M–$10M+
Yearly Specialty Sets
Annual recurring data revenue
8–32X
Premium RWE Data
vs. Clinical Data
Price Trajectory — Steep Decline by Design
$300 Today. $18 Tomorrow. Data Pays for Everything.
Month by month, our mission is to lower the cost of peptides to patients by using their data to support paying for their healthcare.
1
2
3
4
5
1
Retail: $300
2
Month 1: $150–$200
3
Month 3: $100
4
Month 6: $50–$80
5
Month 9: $18 target
The math is simple: Revenue from peptide sales per patient per year is approximately $1,800. Revenue from licensing that same patient's data is $5,000–$50,000. Data is starting at 8X to 32X more valuable than the peptides themselves.
Peptide Revenue / Year
~$1,800 per patient
Data Licensing / Patient
$5,000–$50,000
Data Premium
Starting at 8X to 32X more valuable
Although we can't make claims that peptides cure, we have documented outcomes that traditional medications have not achieved — helping patients get off five to nine medications and addressing conditions at their core.
No competitor can match $18 peptides — because no one else has a data engine funding the subsidy.
The Numbers at Every Level
1
Per Patient — One-Time
$150–180 record retrieval + $100–120 triage + $100–149 gaps-in-care = $350–$450 total
2
Per Patient — Monthly
$50–150 peptide margin + $15–60 billing cut + $120–425 RPM = $185–$635/mo
3
Per Doctor (50 Patients)
$17.5K–$22.5K onboarding + $9.25K–$31.75K monthly + $111K–$381K annual recurring
Scale Economics
10 Doctors
$92.5K–$317.5K/mo
100 Doctors
$925K–$3.18M/mo
1,000 Doctors
$9.25M–$31.8M/mo
RWE Licensing
$3M–$10M+/yr
One System. Five Simultaneous Outcomes.
Eliminates the $300 Acquisition Cost
Replaces it with $350–$450 in new revenue — a net swing of $650–$750 per patient visit.
Complete 15-Year Patient Profiles
Doctors receive a full clinical summary before the patient walks in the door. No guesswork.
IRB-Enrolled Peptide Research
Patients access treatments at 25 cents on the dollar through compliant research enrollment.
Monthly Recurring Revenue
$120–$425 per patient per month via Remote Patient Monitoring — zero manual charting.
The World's Most Valuable Peptide Database
RWE data worth 8–32X clinical data, sellable to pharma for NDA/FDA submissions. $3M–$10M+ annually.
This is not a peptide company. This is a data company that uses peptides to acquire the most valuable healthcare data ever collected.
Current daily snapshot: $100K/day. Target: $500K/day. 100% clinical. Zero outside capital.